2026 NPPES data Hematology & Oncology Physician NPI 1598756363 M.D.
Verify on CMS →

TSUYOSHI INOSHITA, M.D.

Hematology & Oncology Physician in PORTSMOUTH, Ohio. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
2K
Medicare Part D claims · 200 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
86%
generic claims · 14% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
82.9435/100
▼ 0 pts below national avg 83.1 · [object Object]
Industry payments
$2.5K
95 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: TSUYOSHI INOSHITA, M.D. is a Hematology & Oncology Physician ([object Object]) practicing in PORTSMOUTH, Ohio with a Medicare Part D prescribing footprint of 2K claims across 200 beneficiaries — 14% brand-name prescribing . Their CMS MIPS Final Score of 82.9435/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $2.5K across 95 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: TSUYOSHI INOSHITA, M.D. reported a CMS MIPS final score of 82.9435 out of 100, below the 83.1 national average, and filed 1,548 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

TSUYOSHI INOSHITA, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

TSUYOSHI INOSHITA, M.D. at a glance

Near national average

NPI registry status

Active

Issued 11/02/2005

NPI 1598756363

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

1,548 83% vs specialty avg

2023 prescription claims

Specialty avg: 847

MIPS final score

82.9435/100 0.1564999999999941% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in Ohio

How Hematology & Oncology Physician compares to other specialties among Ohio providers

Ohio providers

Hematology & Oncology Physician share within Ohio

1. Hematology & Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hematology & Oncology Physician share within Ohio

Medicare quality performance — MIPS

TSUYOSHI INOSHITA, M.D.'s 2023 MIPS final score plotted against the Hematology & Oncology Physician national average

Near national average
MIPS Final Score
82.9435/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Hematology & Oncology Physician) — 82.9435/100 vs national avg 83.1

0%100%National avg83%82.9%
MIPS final score (Hematology & Oncology Physician) — 82.9435/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

TSUYOSHI INOSHITA, M.D. is a Hematology & Oncology Physician provider practicing in PORTSMOUTH, Ohio, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1598756363. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

TSUYOSHI INOSHITA, M.D. appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding M.D. credentials at 916 11TH ST, PORTSMOUTH, OH, 45662, with a listed phone of (740) 353-4884. NPI 1598756363 was issued on 11/02/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what INOSHITA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,548 prescription claims written by this provider, covering 200 Medicare beneficiaries and totaling roughly $2.9 million in drug spend, split 14% brand-name and 86% generic by claim count, with an opioid prescribing rate of 28.4%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 82.9435/100 for the 2023 performance year (Quality 70.0105, Cost 65.5754), compared with the national average of 83.1.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

916 11TH ST
PORTSMOUTH, OH 45662

Provider Details

NPI 1598756363
Specialty Hematology & Oncology Physician
Credentials M.D.
Gender Male
NPI Issued 11/02/2005

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

82.9435
Final Score
Avg: 83.1
70.0105
Quality
65.5754
Cost
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where TSUYOSHI INOSHITA, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

KINGS DAUGHTERS MEDICAL SPECIALTIES INC
WHEELERSBURG, OH

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for TSUYOSHI INOSHITA, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$2.5K

Largest payer

AstraZeneca Pharmaceuticals LP

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Ohio OMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~48K Ohio medical licensees in 2023 — they are NOT specific to TSUYOSHI INOSHITA, M.D.. To verify TSUYOSHI INOSHITA, M.D.'s current license status, search the OMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

158
Total board actions, Ohio 2023
Across 154 cases
3.29
Actions per 1,000 licensees
Ohio statewide rate
probation
Most common action type
56 cases

OMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Ohio disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

TSUYOSHI INOSHITA, M.D. — brand share 14.0%
Specialty average (est.)

14% brand-name claims vs 86% generic, on 1,548 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,548
Total Claims
$2.9M
Total Drug Cost
200
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,819
Total Day Supply
37,904
Brand vs Generic
14% brand / 86% generic
Brand Drug Cost
$2.7M
Generic Drug Cost
$270K
Opioid Claims
440 (28.4% rate)
Antibiotic Claims
56

Patient Demographics

Average Patient Age
72.2 years
Avg HCC Risk Score
2.14
Gender Split
59% female / 41% male
Age Distribution
<65: 31, 65-74: 88, 75-84: 66, 85+: 15

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Hydrocodone-Acetaminophen
Hydrocodone/Acetaminophen
187
Oxycodone-Acetaminophen
Oxycodone Hcl/Acetaminophen
149
Ondansetron Hcl
84
Imbruvica
Ibrutinib
68
Warfarin Sodium
66
Anastrozole
65
Fentanyl
52
Hydroxyurea
48
Prochlorperazine Maleate
43
Oxycodone Hcl
41

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How TSUYOSHI INOSHITA, M.D. fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

TSUYOSHI INOSHITA, M.D.'s 1,548 claims are above the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in Ohio

Other clinicians with the same primary specialty enrolled in Ohio, drawn from the same CMS NPPES roster as INOSHITA.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is TSUYOSHI INOSHITA, M.D.'s specialty?
TSUYOSHI INOSHITA, M.D. specializes in Hematology & Oncology Physician and practices in PORTSMOUTH, Ohio. Credentials: M.D..
How much does TSUYOSHI INOSHITA, M.D. prescribe under Medicare Part D?
In 2023, TSUYOSHI INOSHITA, M.D. wrote 1,548 Medicare Part D claims totaling $2.9M in drug costs for 200 beneficiaries.
What is TSUYOSHI INOSHITA, M.D.'s Medicare quality score?
TSUYOSHI INOSHITA, M.D. has a CMS MIPS Final Score of 82.9435/100 (Quality: 70.0105, Cost: 65.5754). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is TSUYOSHI INOSHITA, M.D. located?
TSUYOSHI INOSHITA, M.D. is located at 916 11TH ST, PORTSMOUTH, OH, 45662. Phone: (740) 353-4884.
What is TSUYOSHI INOSHITA, M.D.'s NPI number?
TSUYOSHI INOSHITA, M.D.'s National Provider Identifier (NPI) is 1598756363, issued on 11/02/2005.
Does TSUYOSHI INOSHITA, M.D. prescribe more brand-name or generic drugs?
TSUYOSHI INOSHITA, M.D.'s prescribing is 14% brand-name and 86% generic drugs by claim count, with $2.7M in brand drug costs.
Does TSUYOSHI INOSHITA, M.D. prescribe opioids?
Yes, TSUYOSHI INOSHITA, M.D. had 440 opioid claims in 2023 with an opioid prescribing rate of 28.4%.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does TSUYOSHI INOSHITA, M.D. prescribe most often?
Based on 2023 Medicare Part D data, TSUYOSHI INOSHITA, M.D.'s most frequently prescribed drugs include Hydrocodone-Acetaminophen, Oxycodone-Acetaminophen, Ondansetron Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does TSUYOSHI INOSHITA, M.D. accept Medicare?
TSUYOSHI INOSHITA, M.D. appears in CMS Medicare data with 1,548 Part D claims and 200 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify TSUYOSHI INOSHITA, M.D.'s credentials?
TSUYOSHI INOSHITA, M.D.'s NPI is 1598756363 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology